Classified under diversified commercial services, the entity reported nil revenue from operations in FY26, against Rs 18 lakh in FY25. Its total income of Rs 3.32 lakh in FY26 and Rs 2.29 lakh in Q1 FY27 came entirely from other income, with the Q1 net loss narrowing to Rs 2.59 lakh from Rs 3.64 lakh a year earlier. The company posted an FY26 net loss of Rs 18.28 lakh versus a Rs 3.98 lakh profit in FY25, with operating cash flow negative at Rs 21.92 lakh. Cash and cash equivalents jumped to Rs 209.83 lakh from Rs 0.77 lakh, driven by the sale of equity instruments worth Rs 178.52 lakh routed through other comprehensive income. In February 2026 it sold its entire holding of 48,000 equity shares in INOR Medical Products (an unlisted company) to Nowrosjee Wadia and Sons. Despite the operational loss, the board declared a Rs 87 per share dividend on a Rs 10 face value, and total comprehensive income was Rs 142.28 lakh. The entity has 22 shareholders on record and Rs 20 lakh of paid-up equity capital, with its registered office in Ballard Estate, Mumbai. AR · MarketPing reader · 2026-08-03
Revenue streams, as the annual report describes them. Revenue from operations (0%), Other income (100%). Asset-light entity with no operating revenue; functioning largely as an investment holder distributing accumulated cash
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| EBITDA (ex other income) | (0) | (0) | (0) | 0 | (0) |
| margin % | — | — | — | 1.1 | — |
| Owners' profit | (0) | (0) | (0) | 0 | (0) |
| EPS, as reported (₹) | (2.51) | (3.39) | (7.14) | 1.99 | 9.14 |
| ROE % · ROCE % | (5.7) · (5.7) | (8.4) · (8.5) | (21.6) · (21.5) | 5.7 · 5.7 | (8.6) · (7.9) |
| Debt / equity (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from operations | (0) | (0) | (0) | (0) | (0) |
| Capex | 0 | 0 | 0 | 0 | 0 |
| ₹ crore | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | (0) | (0) | (0) | 0 | (0) | (0) | (0) | (0) |
| Net profit | (0) | (0) | (0) | 0 | (0) | (0) | (0) | (0) |
| EPS (₹) | (1.39) | (1.83) | (1.92) | 7.13 | 1.82 | 2.12 | 1.95 | 3.24 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| INTL GEMOLOGICAL INST LTD | 13,611 | 22.3 | 9.15 | 13.1 | 47.8 | 58.1 | — | 64.6 |
| WEWORK INDIA MANAGEMENT L | 9,297 | 106.7 | 31.07 | 5.9 | 25.0 | 1.0 | — | 66.5 |
| NESCO LTD. | 7,728 | 18.6 | 2.58 | 13.1 | 13.8 | 14.8 | 26.2 | 68.9 |
| INOX GREEN ENERGY SER LTD | 7,175 | 57.5 | 4.18 | 42.6 | 6.0 | 9.0 | — | 131.6 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 11 Sept 2026 · CFO and Company Secretary resign; new Director appointed | management changes | high | — | — |
| 11 Sept 2026 · Board appoints new director, CFO and CS resigns | management changes | high | — | — |
| 11 Sept 2026 · CFO and Company Secretary resign; replacements appointed | management changes | high | — | — |
| 11 Sept 2026 · CFO and Company Secretary resign; new director appointed | management changes | high | — | — |
| 11 Sept 2026 · CFO and Company Secretary resign; new director and CS appointed | management changes | high | — | — |
| 11 Sept 2026 · Oseaspre board appoints new director, CFO and CS replaced | management changes | high | — | — |
| 22 Aug 2026 · Oseaspre Consultants re-appoints Independent Director for second 5-year term | management changes | medium | — | — |
| 21 Aug 2026 · Independent Director Nitin Datanwala re-appointed for second 5-year term | management changes | medium | — | — |
| 29 Jul 2026 · Physical shareholders asked to update PAN and KYC details | compliance | minimal | — | — |
| 17 Jul 2026 · Newspaper Publication of Unaudited Q1 FY26 Financial Results | compliance | minimal | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| SMARTWORKS COWORKING SP L | 6,079 | 218.0 | 11.45 | 5.1 | 2.0 | 0.3 | — | 65.8 |
| NIRLON LTD | 5,526 | 16.0 | 11.79 | — | 73.8 | 18.1 | — | 79.4 |
| QUESS CORP LIMITED | 5,174 | 20.4 | 4.43 | 15.6 | 19.0 | 14.4 | 7.1 | 2.6 |
| INDIQUBE SPACES LIMITED | 4,272 | — | 8.30 | — | (20.7) | (2.5) | — | 67.3 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| ROCE | (7.9) | 3.2 | 93 of 105 | 12% |
| ROE | (8.6) | 3.1 | 106 of 116 | 9% |
| Debt / Equity | 0.0 | 0.0 | 3 of 116 | 60% |
| Revenue growth | (100.0) | 16.2 | 89 of 91 | 0% |
| Profit growth | (145.4) | 5.2 | 97 of 110 | 12% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
